Current:Home > InvestAirbnb agrees to pay $621 million to settle a tax dispute in Italy -AssetLink
Airbnb agrees to pay $621 million to settle a tax dispute in Italy
View
Date:2025-04-15 02:10:50
ROME (AP) — Short-term rental platform Airbnb has agreed to pay 576 million euros ($621 million) to settle a years-long dispute over unpaid taxes in Italy but said it won’t try to recover the money from its hosts.
In November, Italian prosecutors said AirBnb owed about 779 million euros ($840 million) in short-term rental taxes it had failed to pay on behalf of Italian landlords who used the platform between 2017 and 2021.
The San Francisco-based company said in a statement on Wednesday that it was working on introducing new tools for hosts to have their taxes withheld automatically and paid to the Italian tax authorities on their behalf.
“The vast majority of hosts on Airbnb in Italy are ordinary families that are using the platform for supplemental income,” the company said in its statement. “We hope the agreement with the Italian Revenue Agency and recent legislative changes will provide these families with certainty about the rules around hosting for years to come.”
The Court of Justice of the European Union ruled in 2022 that member countries could require short-term rental platforms to collect income taxes.
Airbnb said it welcomed clarity provided by the Italian government in next year’s budget law on how platforms should withhold income taxes for non-professional hosts in Italy.
“These improvements will make it easier for historic centers such as Venice and Florence to see who is hosting and how often, and to develop proportionate policy solutions in response. Airbnb is committed to working with Italian authorities to make the rules a success,” the company added.
Italy is a key market for Airbnb, with tens of thousands of hosts using the platform to rent their properties.
The far-right government led by Premier Giorgia Meloni has pledged to crack down on tax evasion related to short-term rentals and aims to raise the tax rate for owners from 21% to 26%.
veryGood! (69799)
Related
- As Trump Enters Office, a Ripe Oil and Gas Target Appears: An Alabama National Forest
- Ariana Madix Reveals the Shocking First Time She Learned Tom Sandoval and Raquel Leviss Had Sex
- Justin Long and Kate Bosworth Are Married One Month After Announcing Engagement
- The Fed is taking a break in hiking interest rates. Here's why.
- Why members of two of EPA's influential science advisory committees were let go
- Standing Rock Leaders Tell Dakota Pipeline Protesters to Leave Protest Camp
- As car thefts spike, many thieves slip through U.S. border unchecked
- A Longchamp Resurgence Is Upon Us: Shop the Iconic Le Pliage Tote Bags Without Paying Full Price
- EU countries double down on a halt to Syrian asylum claims but will not yet send people back
- Love Coffee? It’s Another Reason to Care About Climate Change
Ranking
- B.A. Parker is learning the banjo
- The FDA proposes new targets to limit lead in baby food
- Why Trump didn't get a mugshot — and wasn't even technically arrested — at his arraignment
- Ukraine: The Handoff
- Meet the volunteers risking their lives to deliver Christmas gifts to children in Haiti
- A police dog has died in a hot patrol car for the second time in a week
- In Spain, Solar Lobby and 3 Big Utilities Battle Over PV Subsidy Cuts
- All the Dazzling Details Behind Beyoncé's Sun-Washed Blonde Look for Her Renaissance Tour
Recommendation
Grammy nominee Teddy Swims on love, growth and embracing change
UN Proposes Protecting 30% of Earth to Slow Extinctions and Climate Change
Philadelphia woman killed by debris while driving on I-95 day after highway collapse
Kate Spade 24-Hour Flash Deal: Save 69% On This Overnight Bag That’s Perfect for Summer Travel
Louvre will undergo expansion and restoration project, Macron says
Ariana Grande’s Rare Tribute to Husband Dalton Gomez Is Just Like Magic
Helen Mirren Brings the Drama With Vibrant Blue Hair at Cannes Film Festival 2023
The Top Moisturizers for Oily Skin: SkinMedica, Neutrogena, La Roche-Posay and More